Welcome to The Multiple Sclerosis Journey. Join us for a multimedia exploration of where MS treatment and research stands, what the future of care may hold, and the experiences of clinicians and patients as they collaborate on the frontlines of MS care.
The Multiple Sclerosis Journey will examine new insights on the importance of early diagnosis as well as accurate identification of the four MS phenotypes and how their recognition impacts treatment selection. Join us as we examine the importance of maintaining brain health in sustaining wellness and ability among patients with MS. Experience discussions of the role of patient and physician collaboration in sustaining continuity of care and in tailoring therapy to individual patient needs and preferences.

And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.

The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.

Walk with us.

Featured Articles

Seasons in the sun: The relationship between vitamin D and MS

About one in every three patients with multiple sclerosis (MS) uses complementary medicine in addition to conventional disease-modifying therapy.

Growing number of MS drugs brings challenges

Major federally funded studies are underway to help neurologists better assess a growing array of multiple sclerosis treatments, including competing tablets.
But in the near term, physicians and people with MS will continue to have to make certain educated guesses when choosing medications.

Cognitive reserve may help the brain resist the effects of MS on thinking

During the past few decades, research has made clear that multiple sclerosis causes not only physical disability but also cognitive problems.

MS patients report similar satisfaction with physician, nurse care

When it comes to treating patients with multiple sclerosis (MS), a new study shows that physicians and nurse practitioners (NPs) score similarly in regard to patient satisfaction.

Cost of MS medication may go unspoken in the clinic

The cost of treatment for multiple sclerosis (MS) has been the subject of GoFundMe campaigns, an investigation by members of Congress, and recent studies in Neurology and JAMA Neurology.